The initial public offering (IPO) market is finally picking up much needed momentum as the broader stock market begins to gain some stable footing in the aftermath of the coronavirus stock market crash. Last week saw the introduction of another biotech and three last minute special purpose acquisition companies (SPAC), and the week ahead promises two healthcare related companies and one more SPAC.

ADC Therapeutics SA (ADCT  ) prized its upsized offering above its estimated range at $19 per share to raise about $233 million from over 12 million offered shares. The Swiss Phase 2 oncology-focused biotech had postponed its original October IPO that aimed to raise $1.8 billion in debut. The company priced its IPO at a meaningful discount this time and jumped 56% in its first day, continuing the market's biotech streak.

In addition to ADC, three SPACs raised capital on public markets last week: Jaws Acquisition Corp. raised $600 million with no focused business target, GidCapital3, Inc. raised $200 million to target a company in the tech, media and telecommunications industry, and Novus Capital Corp. raised $100 million with the goal of also acquiring a tech business.

SelectQuote, Inc. leads the market for the week ahead, with the online platform for comparing and buying insurance plans intends to raised $450 million from 25 million shares offered between $17-$19 each. This IPO is profitable, posting a revenue of $464 million for the 12 months ended March 31,2020. EverQuote (EVER  ), a competitor, is up over 37% year-to-date despite current market conditions.

For the rest of the week, Inari Medical aims to raise $100 million from 7.3 million offered shares in the range of $14-$16. The medical device manufacturer noted that the pandemic has negatively impacted the company. B. Riley Principal Merger II, the second SPAC from B. Riley Financial, plans to raise $200 million and has not focused on an industry.